Literature DB >> 17525478

Radiation-induced thyroid cancer: what we have learned from chernobyl.

Yuri E Nikiforov1.   

Abstract

An increased incidence of thyroid cancer in the exposed children remains the most well-documented long-term effect of radioactive contamination after the Chernobyl nuclear accident in April, 1986. Multiple studies on approx 4000 children and adolescents with thyroid cancer have provided important new information about the epidemiological, clinical, pathological, and molecular aspects of radiation-induced carcinogenesis in the thyroid gland. They revealed that environmental exposure to 131I during childhood carries an increased risk of thyroid cancer and the risk is radiation dose dependent. The youngest children are most sensitive to radiation-induced carcinogenesis, and the minimal latent period for thyroid cancer development after exposure is as short as 4 yr. The vast majority of these cancers are papillary carcinomas, many of which have characteristic solid or solid-follicular microscopic appearance. On the molecular level, post-Chernobyl tumors are characterized by frequent occurrence of chromosomal rearrangements, such as RET/PTC, whereas point mutations of BRAF and other genes are much less common in this population.

Entities:  

Mesh:

Year:  2006        PMID: 17525478     DOI: 10.1007/s12022-006-0001-5

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   4.056


  61 in total

1.  Low frequency of BRAFT1796A mutations in childhood thyroid carcinomas.

Authors:  Atsushi Kumagai; Hiroyuki Namba; Vladimir A Saenko; Kiyoto Ashizawa; Akira Ohtsuru; Masahiro Ito; Naofumi Ishikawa; Kiminori Sugino; Koichi Ito; Stephen Jeremiah; Geraldine A Thomas; Tatyana I Bogdanova; Mykola D Tronko; Takeshi Nagayasu; Yoshisada Shibata; Shunichi Yamashita
Journal:  J Clin Endocrinol Metab       Date:  2004-09       Impact factor: 5.958

2.  Differentiated thyroid cancer: clinical characteristics, treatment, and outcome in patients under 21 years of age who present with distant metastases. A report from the Surgical Discipline Committee of the Children's Cancer Group.

Authors:  M P La Quaglia; T Black; G W Holcomb; C Sklar; R G Azizkhan; G M Haase; K D Newman
Journal:  J Pediatr Surg       Date:  2000-06       Impact factor: 2.545

3.  PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas.

Authors:  M Grieco; M Santoro; M T Berlingieri; R M Melillo; R Donghi; I Bongarzone; M A Pierotti; G Della Porta; A Fusco; G Vecchio
Journal:  Cell       Date:  1990-02-23       Impact factor: 41.582

4.  Oncogenic AKAP9-BRAF fusion is a novel mechanism of MAPK pathway activation in thyroid cancer.

Authors:  Raffaele Ciampi; Jeffrey A Knauf; Roswitha Kerler; Manoj Gandhi; Zhaowen Zhu; Marina N Nikiforova; Hartmut M Rabes; James A Fagin; Yuri E Nikiforov
Journal:  J Clin Invest       Date:  2005-01       Impact factor: 14.808

5.  Molecular characterization of RET/PTC3; a novel rearranged version of the RETproto-oncogene in a human thyroid papillary carcinoma.

Authors:  M Santoro; N A Dathan; M T Berlingieri; I Bongarzone; C Paulin; M Grieco; M A Pierotti; G Vecchio; A Fusco
Journal:  Oncogene       Date:  1994-02       Impact factor: 9.867

6.  Frequent activation of ret protooncogene by fusion with a new activating gene in papillary thyroid carcinomas.

Authors:  I Bongarzone; M G Butti; S Coronelli; M G Borrello; M Santoro; P Mondellini; S Pilotti; A Fusco; G Della Porta; M A Pierotti
Journal:  Cancer Res       Date:  1994-06-01       Impact factor: 12.701

7.  Risk of thyroid cancer in the Bryansk Oblast of the Russian Federation after the Chernobyl Power Station accident.

Authors:  Scott Davis; Valery Stepanenko; Nikolai Rivkind; Kenneth J Kopecky; Paul Voillequé; Vladimir Shakhtarin; Evgeni Parshkov; Sergei Kulikov; Evgeni Lushnikov; Alexander Abrosimov; Vladislav Troshin; Galina Romanova; Vladimir Doroschenko; Anatoli Proshin; Anatoly Tsyb
Journal:  Radiat Res       Date:  2004-09       Impact factor: 2.841

8.  Differentiated thyroid carcinoma in childhood: long term follow-up of 72 patients.

Authors:  M Schlumberger; F De Vathaire; J P Travagli; G Vassal; J Lemerle; C Parmentier; M Tubiana
Journal:  J Clin Endocrinol Metab       Date:  1987-12       Impact factor: 5.958

9.  BRAF mutation in papillary thyroid carcinoma.

Authors:  Yoram Cohen; Mingzhao Xing; Elizabeth Mambo; Zhongmin Guo; Guogun Wu; Barry Trink; Uziel Beller; William H Westra; Paul W Ladenson; David Sidransky
Journal:  J Natl Cancer Inst       Date:  2003-04-16       Impact factor: 13.506

Review 10.  Amiodarone-induced thyrotoxicosis and thyroid cancer: clinical, immunohistochemical, and molecular genetic studies of a case and review of the literature.

Authors:  Aly Saad; Mercedes Falciglia; David L Steward; Yuri E Nikiforov
Journal:  Arch Pathol Lab Med       Date:  2004-07       Impact factor: 5.534

View more
  37 in total

1.  [X-ray in trauma and orthopedic surgery. Physical and biological impact, reasonable use, and radiation protection in the operating room].

Authors:  K Dresing
Journal:  Oper Orthop Traumatol       Date:  2011-02       Impact factor: 1.154

2.  Relationships of FOXE1 and ATM genetic polymorphisms with papillary thyroid carcinoma risk: a meta-analysis.

Authors:  Jie Kang; Xian-Zhao Deng; You-Ben Fan; Bo Wu
Journal:  Tumour Biol       Date:  2014-04-24

3.  RET/PTC and PAX8/PPARγ chromosomal rearrangements in post-Chernobyl thyroid cancer and their association with iodine-131 radiation dose and other characteristics.

Authors:  Rebecca J Leeman-Neill; Alina V Brenner; Mark P Little; Tetiana I Bogdanova; Maureen Hatch; Liudmyla Y Zurnadzy; Kiyohiko Mabuchi; Mykola D Tronko; Yuri E Nikiforov
Journal:  Cancer       Date:  2013-02-21       Impact factor: 6.860

4.  Thyroid shielding in cone beam computed tomography: recommendations towards appropriate use.

Authors:  Ruben Pauwels; Keith Horner; Jenia Vassileva; Madan M Rehani
Journal:  Dentomaxillofac Radiol       Date:  2019-07-09       Impact factor: 2.419

Review 5.  Cytogenomics of cancers: from chromosome to sequence.

Authors:  Alain Bernheim
Journal:  Mol Oncol       Date:  2010-06-11       Impact factor: 6.603

6.  Thyroid carcinoma: epidemiology, histology, and diagnosis.

Authors:  Jatin P Shah
Journal:  Clin Adv Hematol Oncol       Date:  2015-04

Review 7.  2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.

Authors:  Bryan R Haugen; Erik K Alexander; Keith C Bible; Gerard M Doherty; Susan J Mandel; Yuri E Nikiforov; Furio Pacini; Gregory W Randolph; Anna M Sawka; Martin Schlumberger; Kathryn G Schuff; Steven I Sherman; Julie Ann Sosa; David L Steward; R Michael Tuttle; Leonard Wartofsky
Journal:  Thyroid       Date:  2016-01       Impact factor: 6.568

8.  Kinase expression and chromosomal rearrangements in papillary thyroid cancer tissues: investigations at the molecular and microscopic levels.

Authors:  H-U G Weier; J Kwan; C-M Lu; Y Ito; M Wang; A Baumgartner; S W Hayward; J F Weier; H F Zitzelsberger
Journal:  J Physiol Pharmacol       Date:  2009-10       Impact factor: 3.011

Review 9.  Mechanisms of chromosomal rearrangements in solid tumors: the model of papillary thyroid carcinoma.

Authors:  Manoj Gandhi; Viktoria Evdokimova; Yuri E Nikiforov
Journal:  Mol Cell Endocrinol       Date:  2009-09-18       Impact factor: 4.102

10.  Increasing incidence of thyroid cancer in the Commonwealth of Pennsylvania.

Authors:  Darrin V Bann; Neerav Goyal; Fabian Camacho; David Goldenberg
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2014-12       Impact factor: 6.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.